In this activity, experts in the treatment of advanced nonmelanoma skin cancers (NMSC) will review 2 case challenges—one in CSCC and the other in BCC—that highlight the latest data and offer learners a unique opportunity to rethink key clinical decisions for optimal patient outcomes.
Upon completion of this activity, participants should be better able to:
Professor, Department of Dermatology, Division of Internal Medicine
University of Texas MD Anderson Cancer Center
Houston, TX
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Featured RMEI CE Activities
Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources
